Tri-Supply
Tri-supply is a joint venture company set up by Gilead Sciences Ltd and Lawrence Laboratories. The company was incorporated in January 2007.
It was set up to produce Atripla which is a combination of Sustiva, manufactured by Lawrence Laboratories and Truvada, manufactured by Gilead Sciences Limited. Atripla is the company’s only product.
It was the first once-daily single tablet regimen for HIV-1 infection intended as a stand-alone therapy or in combination with other antiretrovirals.
Financial Data
-
31st Dec 16 Source: CRO
- €98.3 million turnover
-
€44,242
profit
-
31st Dec 15 Source: CRO
- €172.6 million turnover
-
-€82
profit - 0 employees
- 5 more years available »
Ranking
By Turnover
(€98.3 million)- 474th in Top Companies
- 50th in Pharma
-
- €98.3 million
Employees
- David Cadogan Director
Latest News
- 8:27am Mainstay Medical appoints new CFO
- 8:05am Ulster Bank confirms Jane Howard’s appointment as new CEO
- 7:21am Greece’s bailout is ending but the pain is far from over
- 7:17am Pre-tax profits soar at Kenmare Resources on record shipments
- 6:44am UK home prices dip with London leading ‘late summer sale’